selected scholarly activity
-
academic article
- A Canadian Multicenter Trial Assessing Memory and Executive Functions in Patients With Schizophrenia Spectrum Disorders Treated With Olanzapine. Journal of Clinical Psychopharmacology. 23:400-404. 2003
- A dose-finding study with remoxipride in the acute treatment of schizophrenic patients.. Journal of Psychiatry and Neuroscience Psychiatric Journal of the University of Ottawa. 17:134-145. 1992
- A controlled dose-ranging study of remoxipride and haloperidol in schizophrenia - a Canadian multicentre trial. Acta Psychiatrica Scandinavica. 82:72-77. 1990
- IS PSYCHIATRY BEING HARMED BY INVOLUNTARY HOSPITALIZATION AND TREATMENT. CMAJ. 137:586-587. 1987
- Decrease of CSF dopamine, its metabolites, and noradrenalin after withdrawal of chronic neuroleptic treatment in schizophrenic patients. Psychiatry Research. 12:177-178. 1984
- Effect of combined haloperidol-lithium treatment on in vitro RBC lithium uptake in patients with affective disorders. Progress in Neuro-Psychopharmacology and Biological Psychiatry Progress in Neuro-Psychopharmacology. 7:831-834. 1983
- Lymphocyte 3H-spiroperidol binding in schizophrenia: preliminary findings. Progress in Neuro-Psychopharmacology and Biological Psychiatry Progress in Neuro-Psychopharmacology. 7:729-732. 1983
-
conference paper
- Assessment of salivation in patients on clozapine. Schizophrenia Research. 185-185. 2000